We present a patient with acromesomelic chondrodysplasia and genital anomalies caused by a novel homozygous mutation in BMPR1B, the gene coding for bone morphogenetic protein receptor 1B. The 16 year old girl, the offspring of a multiconsanguinous family, showed a severe form of limb malformation consisting of aplasia of the fibula, severe brachydactyly, ulnar deviation of the hands, and fusion of carpal/tarsal bones. In addition, she presented with hypoplasia of the uterus and ovarian dysfunction resulting in hypergonadotrophic hypogonadism. Mutation analysis of BMPR1B revealed a homozygous 8 bp deletion (del359-366). This mutation is expected to result in a loss of function and is thus different from the heterozygous missense mutations in BMPR1B recently shown to cause brachydactyly type A2 through a dominant negative effect. The patient's skeletal phenotype shows an overlap with the clinical spectrum of the acromesomelic chondrodysplasias of the Grebe, HunterThompson, and DuPan types caused by homozygous mutations in the gene coding for growth differentiation factor 5 (GDF5) which is a high-affinity ligand to BMPR1B. However, the phenotype described here differs from GDF5 associated chondrodysplasias because of the additional presence of genital anomalies and the distinct limb phenotype. O steochondrodysplasias are a clinically and genetically heterogeneous group of disorders.
We present a patient with acromesomelic chondrodysplasia and genital anomalies caused by a novel homozygous mutation in BMPR1B, the gene coding for bone morphogenetic protein receptor 1B. The 16 year old girl, the offspring of a multiconsanguinous family, showed a severe form of limb malformation consisting of aplasia of the fibula, severe brachydactyly, ulnar deviation of the hands, and fusion of carpal/tarsal bones. In addition, she presented with hypoplasia of the uterus and ovarian dysfunction resulting in hypergonadotrophic hypogonadism. Mutation analysis of BMPR1B revealed a homozygous 8 bp deletion (del359-366). This mutation is expected to result in a loss of function and is thus different from the heterozygous missense mutations in BMPR1B recently shown to cause brachydactyly type A2 through a dominant negative effect. The patient's skeletal phenotype shows an overlap with the clinical spectrum of the acromesomelic chondrodysplasias of the Grebe, HunterThompson, and DuPan types caused by homozygous mutations in the gene coding for growth differentiation factor 5 (GDF5) which is a high-affinity ligand to BMPR1B. However, the phenotype described here differs from GDF5 associated chondrodysplasias because of the additional presence of genital anomalies and the distinct limb phenotype. O steochondrodysplasias are a clinically and genetically heterogeneous group of disorders. 1 Acromesomelic chondrodysplasias are a rare subgroup of these hereditary skeletal disorders characterised by short stature, very short limbs, and hand/foot malformations. The severity of limb abnormalities increases from proximal to distal with profoundly affected hands and feet showing brachydactyly and/or rudimentary fingers (knob-like fingers). The most severe type of the acromesomelic chondrodysplasias is known as Grebe syndrome, followed by the milder phenotypes of Hunter-Thompson and DuPan syndromes. These three related disorders share an autosomal recessive inheritance pattern and are caused by homozygous mutations in growth differentiation factor 5 (GDF5). Heterozygous carriers of GDF5 mutations are usually affected by brachydactyly type C (BDC), 2-4 a condition characterised by brachymesophalangy of index, middle, and little fingers and shortening of the first metacarpal. Ring fingers are only mildly affected and hyperphalangy of the index and middle fingers occurs. However, as shown recently, BDC can also be caused by a homozygous mutation in GDF5.
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GDF5 belongs to the bone morphogenetic proteins (BMPs) of the transforming growth factor-b (TGF-b) superfamily. GDF5 plays an essential role in chondrocyte condensation and differentiation as well as in joint formation as demonstrated by the brachypodism (bp) mouse which carries a loss of function mutation in Gdf5. [6] [7] [8] The limb phenotype of the bp mutant consists of aplasia/hypoplasia of the middle and proximal phalanges and the metacarpals/metatarsals. The murine phenotype thus resembles the human homozygous GDF5 mutations. GDF5 signalling requires binding to the serine/threonine kinase type of bone morphogenetic protein receptors (BMPRs). Three BMPRs are known (BMPR1A, BMPR1B, BMPR2) that are able to form multimeric complexes at the cell surface. 9 10 Binding of the ligand results in dimerisation of the type 2 receptor with one of the type 1 receptors and its subsequent transphosphorylation. Activation of the receptor complex results in phosphorylation of Smads that translocate in the nucleus where they regulate the transcription of target genes.
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Inactivation of BmpR1b in the mouse results in severe brachydactyly similar to the bp mutant mouse. 12 13 In addition, female BmpR1b 2/2 mice are infertile indicating that BmpR1b plays a major role in the female reproductive system. 14 This has also been shown in other species, for example in Booroola Mérino sheep, in which a specific BmpR1b missense mutation (Q249R) increases the ovulation rate and results in twin and triplet births. [15] [16] [17] Recently, we demonstrated that heterozygous missense mutations in BMPR1B cause autosomal dominant inherited brachydactyly A2 (BDA2), a condition characterised by short and lateral deviated index and little fingers and normal fertility. 18 Here we present a patient with a novel homozygous mutation in BMPR1B who has severe acromesomelic dysplasia and ovarian dysfunction. of the distal phalanges of the middle fingers was altered and appeared bifurcated. The metacarpals II-V were of normal length, but metacarpals I were rudimentary. Both thumbs consisted only of a distal phalanx and the proximal phalanges were missing ( fig 2B) . The carpal bones showed an abnormal configuration and several bones were fused. On the right hand, the trapezium, capitate, and scaphoid bones and the hamate, triquetral, and lunate bones were fused; only the pisiform bone was separated but dislocated. On the left hand, except for an abnormally shaped pisiform bone, all other carpal bones were fused. The ulna was short and the radius appeared broad with an expanded distal epiphysis. At the age of 16, the epiphysial plate of the ulna and the radius were not closed indicating retardation of bone age. The feet showed a bilateral clubfoot deformity with small broad feet and short toes that appeared constricted at their bases ( fig 2E) . The toe nails were present. Radiographs of the lower leg ( fig 2F) displayed deformed tibiae with wide proximal metaphyses and aplasia of the fibulae resulting in bilateral dislocation of the tibiotalar joints. The tarsal bones were partly fused, but the metatarsals were not affected. A radiograph of the pelvis ( fig 2G) showed short femoral necks and deformed femoral heads with irregular joint spaces; the femoral growth plates were not completely closed. Clinical examination showed limited cervical spine movements, but no radiograph of the cervical vertebrae was obtained.
METHODS

Case report
In addition to the skeletal phenotype, the patient presented with genital anomalies and primary amenorrhea. Upon ultrasound examination, the ovaries were not present and the uterus was shown to be hypoplastic. Endocrinological studies confirmed hypergonadotrophic hypogonadism indicating a disturbance in ovarian function, with luteinising hormone (LH) 32 IE/l (standard values in follicle maturation and luteal phase: 2-20 IE/l, mid-cycle peak: up to 100 IE/l), follicle stimulating hormone (FSH) 80 IE/l (standard values in follicle maturation and luteal phase: 2-8 IE/l, mid-cycle peak: up to 25 IE/l, postmenopausal value: 20-100 IE/l), and oestradiol ,13 pg/ml (cycle dependent values 30-350 pg/ml, postmenopausal value: 10-35 pg/ml). The patient receives hormonal substitution therapy. The diagnostics of LH, FSH, and oestradiol in the patient's mother and two sisters revealed standard values according to their age. There was no family history of skeletal disorders. The height of the parents was 162 cm (father, 3rd centile for Turkish men) and 150 cm (mother, 10th centile for Turkish women). Clinical examination of the proband's parents and siblings showed no obvious anomalies of the hands or feet.
Metacarpophalangeal profiles
To test for minimal symptoms of brachydactyly, metacarpophalangeal profiles (MCPPs) of hand radiographs of family members were carried out. For analysis of MCPPs, the program ''Antro-Radiological Anthropometry of the Hand'' was used. Further information about this programme can be obtained from www.hosenfeld.de/friedel/antro/antromai. htm.
Molecular analysis
Genomic DNA was extracted from peripheral blood samples by standard methods. The coding region of BMPR1B, consisting of 10 exons, was amplified by standard PCR protocols using a published primer set. 18 PCR products were analysed on 2% agarose gels. Purified PCR products were sequenced in both directions using PCR primers as sequencing primers and the ABI Prism BigDye terminator cycle sequencing reaction kit (Applied Biosystems, Foster City, CA, USA). The products were evaluated on an ABI 3100 DNA sequencer (Applied Biosystems).
The entire coding region of GDF5 was also amplified and sequenced. Exact PCR conditions and primers are reported elsewhere. 5 
RESULTS
Sequencing of GDF5 and BMPR1B
Because of the skeletal phenotype of acromesomelic chondrodysplasia in the patient, we first sequenced GDF5; a mutation in GDF5 was not found. Since the brachydactyly phenotypes associated with GDF5 and BMPR1B mutations show overlapping features, we then sequenced BMPR1B. We performed mutation screening of BMPR1B in the affected girl, her parents, her two sisters, and her two brothers. In the patient, a homozygous 8 bp deletion (del359-366) in exon 4 of BMPR1B (fig 3) was identified. The mutation lies within the extracellular ligand binding domain of BMPR1B as shown in fig 4 and is predicted to result in a frame shift including the transmembranous and the entire intracellular domain of the receptor. Both parents and two siblings were heterozygous for the same mutation and two siblings were found to have both wt alleles.
Metacarpophalangeal profiles
MCPP analysis of hand radiographs demonstrated a discrete shortening (not exceeding the 2nd deviation in SD) of some distal phalanges in heterozygous mutation carriers I-2 and II-3 and also in individual II-1 who had two wt alleles. The lengths of metacarpals, and proximal and middle phalanges were within regular limits. In particular, the bones of the second ray affected in BDA2 were not altered in shape or length. Individual I-1, who is heterozygous for the BMPR1B mutation, showed a normal hand radiograph. These MCPP findings indicate that mutation carrier status is not associated with mild signs of brachydactyly.
DISCUSSION
In this report, we present a 16 year old girl with acromesomelic chondrodysplasia, genital anomalies, amenorrhea, and hypergonadotrophic hypogonadism due to a homozygous mutation in BMPR1B. The skeletal phenotype observed in this individual is distinct from the limb malformations described in other chondrodysplasias. The association of acromesomelic dysplasia with genital anomalies and ovarian dysfunction are novel and argue for a new subtype within the group of acromesomelic dysplasias. The mutation described here causes a frame shift in the region coding for the extracellular domain of BMPR1B and can thus be expected to result in a loss of function. BMPR1B is the major receptor for GDF5, 19 a signalling molecule of the BMP family that plays a major role in digit formation, joint development, and chondrocyte differentiation. Mutations in GDF5 and mutations that result in a non-functional BMP1B receptor, as in the case described here, can thus be expected to give rise to overlapping phenotypes.
The patient presented here shows many features overlapping with Grebe, Hunter-Thompson, and DuPan syndrome patients. In all conditions there is severe shortening of the fingers. Forearms and lower legs are severely shortened, the carpal/tarsal bones are deformed, and the metacarpals/ metatarsals are short. In general, the condition described here is much less severe than Grebe syndrome and very similar to DuPan syndrome. Both DuPan syndrome and the phenotype described here have hypoplastic/absent fibulae and knob-like toes, and the hands are less severely affected than in Grebe syndrome. However, there are specific changes of the hand and foot bones that are unique and that distinguish the individual presented here from previously published cases. The metacarpal and metatarsal bones II-V are relatively normal, whereas in Hunter-Thompson and DuPan syndromes they are shortened to variable degrees. [20] [21] [22] [23] The extensive fusion of carpal/tarsal bones as observed in our patient is also not a typical feature of these conditions. BmpR1b inactivation in the mouse results in a phenotype very similar to that presented here. BmpR1b 2/2 mice display skeletal malformations that are restricted to the appendicular skeleton consisting of hypoplasia/aplasia of all phalanges and fusion of carpal/tarsal bones but relatively normal metacarpals/metatarsals. 12 13 24 The hands and feet of heterozygous BMPR1B mutation carriers in this family showed no signs of brachydactyly. MCPP analysis, a sensitive method to detect shortening of tubular hand bones, also showed no characteristic pattern for heterozygous mutation carriers. The lack of brachydactyly in heterozygous mutation carriers of a presumably loss of function mutation leads to the conclusion that one wt BMPR1B allele is sufficient for proper bone formation in hands and feet. In contrast, heterozygous amino acid substitutions in the intracellular part of BMPR1B have been shown to cause BDA2 by acting in a dominant negative manner. 18 Thus, specific missense mutations in BMPR1B result in a stronger effect than mere haploinsufficiency. In contrast, heterozygous carriers of loss of function mutations in the BMPR1B ligand GDF5 are affected with BDC. 2 4 25 The dominant character of these mutations indicates that GDF5 has important functions that are not transmitted via the BMP1B receptor and that other receptors are important in this particular phase of skeletal development. The dominant mechanism could also suggest that the ligand GDF5 is essential for proper skeletal development and that haploinsufficiency of GDF5 has a significantly stronger effect than haploinsufficiency of BMPR1B.
Female BmpR1b 2/2 mice are infertile due to irregular oestrous cycles, reduced quantity of cumulus cell-oocyte complexes in tertiary follicles, and a failure in proper uterine endometrial gland development. In vivo, oocytes of BmpR1b 2/2 mice cannot be fertilised as a result of disordered cell expansion of cumuluscells, which are necessary for effective sperm penetration. 14 The importance of BMP signalling in ovarian function has been supported by the identification of mutations in ligands and receptors of the BMP pathway in sheep. A Q249R mutation in BmpR1b in Booroola Mérino sheep was shown to be associated with a higher ovulation rate and increased litter size. The mutation has an additive effect on reproduction with each mutation copy generating one or two extra lambs on average. [15] [16] [17] The importance of the BMP pathway in the regulation of the ovulation rate is underlined by mutations in BMP15, another ligand of BMPRs, found in Inverdale and Hanna sheep. 26 27 In these strains, heterozygous mutations in BMP15 result in an increased ovulation rate, whereas homozygous mutations lead to small non-functional streak ovaries with primary ovarian failure and infertility.
Sheep with BMPR1B or BMP15 missense mutations do not show a skeletal phenotype. In contrast, BmpR1b 2/2 mice caused by a kinase deletion in BmpR1b present with brachydactyly and infertility.
14 Thus, the skeletal and genital phenotype of the BmpR1b 2/2 mouse is similar to the clinical anomalies associated with the human BMPR1B mutation described in this report. The presence of acromesomelic dysplasia associated with ovarian and uterine disorder in the female patient described here highlights the dual function of BMPR1B in skeletal development as the predominant receptor for GDF5 on one hand and its role in genital development and ovarian function on the other. Further investigations of BMPR1B mutations and the characterisation of associated phenotypes will be of interest in understanding the exact biological function of BMPR1B in humans.
